Ethical Issues in Drug Development
Start with the big picture
Ethical clinical research requires voluntary, understandable, documented consent that continues as studies evolve, along with IRB or IEC approval before human research begins. Reviewers assess whether anticipated therapeutic value justifies foreseeable harms, while researchers must take extra care with vulnerable participants and ensure fair selection. The topic also addresses privacy, injury compensation, conflicts of interest, accurate data practices, and publication of negative or inconclusive findings. It considers when placebo use may be acceptable, responsibilities for post-trial access, and safeguards for animal studies and first-in-human dosing. Broader sections introduce ethical questions in global trials, genetic and biomarker research, environmental impact, and the use of traditional or Indigenous knowledge.
What you'll learn
- Explain core requirements for informed consent and IRB/IEC approval.
- Describe how ethical risk-benefit assessment and participant selection protect research participants.
- Identify safeguards for vulnerable populations, privacy, and research-related injury.
- Recognize responsibilities for data integrity, results publication, and post-trial access.
- Outline ethical considerations across animal studies, early human dosing, and broader research contexts.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.